Crescentic glomerulonephritis associated with p-ANCA positivity in fludarabine-treated chronic lymphocytic leukaemia.
Tisler
A
A
Division of Nephrology, Wellesley Hospital, University of Toronto, Ontario, Canada.
Pierratos
A
A
Lipton
J H
JH
D000368:Aged; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D005921:Glomerulonephritis / Q000097:blood / Q000209:etiology* / Q000276:immunology; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D019268:Antibodies, Antineutrophil Cytoplasmic; D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine